Deletion of a pathogenic mutation-containing exon of COL7A1 allows clonal gene editing correction of RDEB patient epidermal stem cells

Recessive dystrophic epidermolysis bullosa is a severe skin fragility disease caused by loss of functional type VII collagen at the dermal-epidermal junction. A frameshift mutation in exon 80 of COL7A1 gene, c.6527insC, is highly prevalent in the Spanish patient population. We have implemented gene-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Mencía, Ángeles (VerfasserIn) , Chamorro, Cristina (VerfasserIn) , Bonafont, Jose (VerfasserIn) , Duarte, Blanca (VerfasserIn) , Holguin, Almudena (VerfasserIn) , Illera, Nuria (VerfasserIn) , Llames, Sara G. (VerfasserIn) , Escámez, Maria José (VerfasserIn) , Haußer-Siller, Ingrid (VerfasserIn) , Del Río, Marcela (VerfasserIn) , Larcher, Fernando (VerfasserIn) , Murillas, Rodolfo (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2018
In: Molecular therapy. Nucleic Acids
Year: 2018, Jahrgang: 11, Pages: 68-78
ISSN:2162-2531
DOI:10.1016/j.omtn.2018.01.009
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.omtn.2018.01.009
Volltext
Verfasserangaben:Ángeles Mencía, Cristina Chamorro, Jose Bonafont, Blanca Duarte, Almudena Holguin, Nuria Illera, Sara G. Llames, Maria José Escámez, Ingrid Hausser, Marcela Del Río, Fernando Larcher, and Rodolfo Murillas

MARC

LEADER 00000caa a2200000 c 4500
001 1693486954
003 DE-627
005 20240405193208.0
007 cr uuu---uuuuu
008 200330s2018 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.omtn.2018.01.009  |2 doi 
035 |a (DE-627)1693486954 
035 |a (DE-599)KXP1693486954 
035 |a (OCoLC)1341311518 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Mencía, Ángeles  |e VerfasserIn  |0 (DE-588)1207290785  |0 (DE-627)1693487969  |4 aut 
245 1 0 |a Deletion of a pathogenic mutation-containing exon of COL7A1 allows clonal gene editing correction of RDEB patient epidermal stem cells  |c Ángeles Mencía, Cristina Chamorro, Jose Bonafont, Blanca Duarte, Almudena Holguin, Nuria Illera, Sara G. Llames, Maria José Escámez, Ingrid Hausser, Marcela Del Río, Fernando Larcher, and Rodolfo Murillas 
264 1 |c 2018 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 30.03.2020 
520 |a Recessive dystrophic epidermolysis bullosa is a severe skin fragility disease caused by loss of functional type VII collagen at the dermal-epidermal junction. A frameshift mutation in exon 80 of COL7A1 gene, c.6527insC, is highly prevalent in the Spanish patient population. We have implemented gene-editing strategies for COL7A1 frame restoration by NHEJ-induced indels in epidermal stem cells from patients carrying this mutation. TALEN nucleases designed to cut within the COL7A1 exon 80 sequence were delivered to primary patient keratinocyte cultures by non-integrating viral vectors. After genotyping a large collection of vector-transduced patient keratinocyte clones with high proliferative potential, we identified a significant percentage of clones with COL7A1 reading frame recovery and Collagen VII protein expression. Skin equivalents generated with cells from a clone lacking exon 80 entirely were able to regenerate phenotypically normal human skin upon their grafting onto immunodeficient mice. These patient-derived human skin grafts showed Collagen VII deposition at the basement membrane zone, formation of anchoring fibrils, and structural integrity when analyzed 12 weeks after grafting. Our data provide a proof-of-principle for recessive dystrophic epidermolysis bullosa treatment through ex vivo gene editing based on removal of pathogenic mutation-containing, functionally expendable COL7A1 exons in patient epidermal stem cells. 
650 4 |a COL7A1 
650 4 |a dystrophic epidermolysis bullosa 
650 4 |a epidermal stem cells 
650 4 |a gene editing 
650 4 |a gene therapy 
650 4 |a genetic disease 
650 4 |a RDEB 
650 4 |a skin 
650 4 |a TALEN 
700 1 |a Chamorro, Cristina  |e VerfasserIn  |4 aut 
700 1 |a Bonafont, Jose  |e VerfasserIn  |4 aut 
700 1 |a Duarte, Blanca  |e VerfasserIn  |4 aut 
700 1 |a Holguin, Almudena  |e VerfasserIn  |4 aut 
700 1 |a Illera, Nuria  |e VerfasserIn  |4 aut 
700 1 |a Llames, Sara G.  |e VerfasserIn  |4 aut 
700 1 |a Escámez, Maria José  |e VerfasserIn  |4 aut 
700 1 |a Haußer-Siller, Ingrid  |d 1957-  |e VerfasserIn  |0 (DE-588)1058096710  |0 (DE-627)796384703  |0 (DE-576)163782377  |4 aut 
700 1 |a Del Río, Marcela  |e VerfasserIn  |4 aut 
700 1 |a Larcher, Fernando  |e VerfasserIn  |4 aut 
700 1 |a Murillas, Rodolfo  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Molecular therapy. Nucleic Acids  |d New York, NY : Nature Publ. Group, 2012  |g 11(2018), Seite 68-78  |h Online-Ressource  |w (DE-627)718632702  |w (DE-600)2662631-7  |w (DE-576)365782785  |x 2162-2531  |7 nnas  |a Deletion of a pathogenic mutation-containing exon of COL7A1 allows clonal gene editing correction of RDEB patient epidermal stem cells 
773 1 8 |g volume:11  |g year:2018  |g pages:68-78  |g extent:11  |a Deletion of a pathogenic mutation-containing exon of COL7A1 allows clonal gene editing correction of RDEB patient epidermal stem cells 
856 4 0 |u https://doi.org/10.1016/j.omtn.2018.01.009  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200330 
993 |a Article 
994 |a 2018 
998 |g 1058096710  |a Haußer-Siller, Ingrid  |m 1058096710:Haußer-Siller, Ingrid  |d 910000  |d 912000  |e 910000PH1058096710  |e 912000PH1058096710  |k 0/910000/  |k 1/910000/912000/  |p 9 
999 |a KXP-PPN1693486954  |e 3615691229 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"doi":["10.1016/j.omtn.2018.01.009"],"eki":["1693486954"]},"note":["Gesehen am 30.03.2020"],"name":{"displayForm":["Ángeles Mencía, Cristina Chamorro, Jose Bonafont, Blanca Duarte, Almudena Holguin, Nuria Illera, Sara G. Llames, Maria José Escámez, Ingrid Hausser, Marcela Del Río, Fernando Larcher, and Rodolfo Murillas"]},"recId":"1693486954","language":["eng"],"relHost":[{"name":{"displayForm":["American Society of Gene & Cell Therapy"]},"language":["eng"],"part":{"text":"11(2018), Seite 68-78","pages":"68-78","extent":"11","year":"2018","volume":"11"},"title":[{"partname":"Nucleic Acids","title_sort":"Molecular therapy","title":"Molecular therapy"}],"titleAlt":[{"title":"Molecular Therapy / Nucleic Acids"}],"pubHistory":["1.2012 -"],"origin":[{"publisherPlace":"New York, NY","dateIssuedKey":"2012","dateIssuedDisp":"2012-","publisher":"Nature Publ. Group"}],"recId":"718632702","id":{"zdb":["2662631-7"],"eki":["718632702"],"issn":["2162-2531"]},"note":["Gesehen am 19. Januar 2017"],"physDesc":[{"extent":"Online-Ressource"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Deletion of a pathogenic mutation-containing exon of COL7A1 allows clonal gene editing correction of RDEB patient epidermal stem cellsMolecular therapy. Nucleic Acids"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"2018"}],"physDesc":[{"extent":"11 S."}],"person":[{"role":"aut","given":"Ángeles","roleDisplay":"VerfasserIn","family":"Mencía","display":"Mencía, Ángeles"},{"family":"Chamorro","display":"Chamorro, Cristina","given":"Cristina","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Bonafont","display":"Bonafont, Jose","role":"aut","roleDisplay":"VerfasserIn","given":"Jose"},{"family":"Duarte","display":"Duarte, Blanca","role":"aut","given":"Blanca","roleDisplay":"VerfasserIn"},{"display":"Holguin, Almudena","family":"Holguin","roleDisplay":"VerfasserIn","given":"Almudena","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","given":"Nuria","display":"Illera, Nuria","family":"Illera"},{"family":"Llames","display":"Llames, Sara G.","given":"Sara G.","roleDisplay":"VerfasserIn","role":"aut"},{"roleDisplay":"VerfasserIn","given":"Maria José","role":"aut","family":"Escámez","display":"Escámez, Maria José"},{"role":"aut","given":"Ingrid","roleDisplay":"VerfasserIn","family":"Haußer-Siller","display":"Haußer-Siller, Ingrid"},{"role":"aut","roleDisplay":"VerfasserIn","given":"Marcela","display":"Del Río, Marcela","family":"Del Río"},{"family":"Larcher","display":"Larcher, Fernando","role":"aut","roleDisplay":"VerfasserIn","given":"Fernando"},{"family":"Murillas","display":"Murillas, Rodolfo","role":"aut","given":"Rodolfo","roleDisplay":"VerfasserIn"}],"title":[{"title":"Deletion of a pathogenic mutation-containing exon of COL7A1 allows clonal gene editing correction of RDEB patient epidermal stem cells","title_sort":"Deletion of a pathogenic mutation-containing exon of COL7A1 allows clonal gene editing correction of RDEB patient epidermal stem cells"}]} 
SRT |a MENCIAANGEDELETIONOF2018